» Articles » PMID: 20571246

Prognostic Value of Post-ischemic Stunning As Assessed by Gated Myocardial Perfusion Single-photon Emission Computed Tomography: a Subanalysis of the J-ACCESS Study

Overview
Journal Circ J
Date 2010 Jun 24
PMID 20571246
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To determine the prognostic value of post-ischemic stunning, the Japanese assessment of cardiac event and survival study by quantitative gated myocardial single-photon emission computed tomography (SPECT) (J-ACCESS) study was reevaluated.

Methods And Results: Of the 4,031 patients of the J-ACCESS, the present study evaluated 1,089 who completed gated SPECT both after stress and at rest. To assess post-ischemic stunning, the following measurements (left ventricular volumes after stress minus volumes at rest) were made: Deltaend-systolic volume (DeltaESV), Deltaenddiastolic volume (DeltaEDV) and Deltaejection fraction (DeltaEF). Myocardial stunning defined either as DeltaESV >or=5 ml, DeltaEDV >or=5 ml or DeltaEF <or=5% was observed in 21%, 22%, or 26%, respectively. During a 3-year follow-up, 101 cardiac events occurred. Kaplan-Meier survival estimation indicated worse event-free survival rates in patients with dilated ESV, dilated EDV, LVEF <or=45%, DeltaESV >or=5 ml or DeltaEDV >or=5 ml than in those without, whereas DeltaEF <or=5% did not predict events. Multivariate analysis demonstrated that LVEF <or=45% was the independent predictor for cardiac events. Nevertheless, DeltaEDV >or=5 ml was also an independent parameter, in addition to LVEF <or=45%, to predict the combined endpoint of cardiac death, myocardial infarction, and revascularization, but excluding heart failure.

Conclusions: These results indicate that post-ischemic stunning, as assessed by gated SPECT, is a marker for poor prognosis, particularly for ischemic cardiac events.

Citing Articles

Association between an Early Revascularization Strategy and Major Cardiac Events Based on Left Ventricular Dyssynchrony in Patients at Intermediate Risk of Major Cardiac Events Using the J-ACCESS Risk Model.

Tanaka Y, Yoda S, Fukumoto K, Hatta T, Kuronuma K, Suzuki Y Intern Med. 2024; 63(20):2739-2750.

PMID: 38432965 PMC: 11557194. DOI: 10.2169/internalmedicine.3039-23.


The evolution of the prognostic value of regadenoson SPECT myocardial perfusion imaging.

Sidhu G, Hendel R J Nucl Cardiol. 2020; 28(6):2808-2811.

PMID: 32468300 DOI: 10.1007/s12350-020-02208-y.


Better characterization of dipyridamole-induced myocardial stunning by systolic wall thickening. A gated perfusion SPECT study.

Bestetti A, Cuko B, Gasparini M, De Servi S J Nucl Cardiol. 2018; 27(1):137-146.

PMID: 29951894 DOI: 10.1007/s12350-018-1340-6.


Extracorporeal Cardiopulmonary Resuscitation in Children of Asia Pacific: A Retrospective Analysis of Extracorporeal Life Support Organization Registry.

Chen G, Qiao Y, Ma J, Wang J, Hei F, Yu J Chin Med J (Engl). 2018; 131(12):1436-1443.

PMID: 29893360 PMC: 6006813. DOI: 10.4103/0366-6999.233946.


Do we really need to look at volumetric measurements with Tc single photon emission computed tomography (SPECT) myocardial perfusion imaging?.

Benz D, Giannopoulos A J Nucl Cardiol. 2018; 26(5):1717-1719.

PMID: 29589207 DOI: 10.1007/s12350-018-1263-2.